Home > Healthcare > Analytical Instruments > Molecular Analysis > PCR Technologies Market
PCR Technologies Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032
- Report ID: GMI5551
PCR Technologies Market Size
PCR Technologies Market size is poised to record robust growth from 2024-2032 attributed to widespread application in genetic sequencing, cloning, detecting mutations, parenting testing, genetic engineering, and forensic science. The rising incidence of infectious diseases, genetic disorders and mutations is driving the demand for PCR technologies. The demand for portable PCR platforms is surging as healthcare settings are prioritizing rapid diagnosis and treatment decisions. Advancements in miniaturization and automation are further enhancing the accessibility and usability of PCR devices at the point of care.
Moreover, PCR & NGS based diagnostics tests are gaining significant prominence for diagnosing COVID-19, resulting in a surge in demand for PCR instruments, reagents, and consumables. The pandemic underscored the importance of PCR technologies in public health response efforts. Additionally, the ongoing developments in automation, miniaturization, and data analysis software are helping to streamline workflows, increase efficiency, and reduce turnaround times.
However, the market may face restraints due to regulatory challenges, such as obtaining approvals for new assays and navigating evolving compliance requirements, which could slow down the product development and market entry to some extent.
PCR Technologies Market Trends
The ongoing technological innovations for catering to diverse research and clinical needs are accelerating the adoption of PCR technologies in genomics, diagnostics, and personalized medicine. For instance, in November 2023, Qiagen introduced new kits for use with its QIAcuity system, as well as a significant new software upgrade, to broaden the range of applications for digital PCR technology in cell and gene therapies, DNA and RNA quantification, and food and pharmaceutical safety. Furthermore, advances, such as digital PCR, multiplex PCR, and isothermal amplification techniques are leading to expanded application scopes, improved sensitivity, and enhanced throughput.
PCR Technologies Market Analysis
The market is segmented into reagents & consumables, instruments, software & services, and hyphenated instruments. Among these, the reagents & consumables segment is anticipated to account for a considerable revenue share by 2032 driven by the expanding applications of PCR technologies in clinical disease diagnosis and genetic & molecular research. Several industry players are also undertaking various strategic initiatives, such as long-term contracts for the sale of reagents or bundled sales of consumables.
The PCR technologies market is segmented into hospital & diagnostics centers, healthcare industry, research & academic institutes, pharma-biotech companies, applied industries, and others. The hospital & diagnostic center segment may generate substantial gains between 2024 and 2032. With the increasing prevalence of infectious diseases & genetic disorders, the use of PCR in hospitals and diagnostic centers for disease diagnosis has turned imperative. The increasing focus on PCR in research & development activities will further drive the preference for pharmaceutical and biotechnology companies.
The North America PCR technologies market is set to exhibit robust growth rate during 2024-2032 owing to the increasing demand for technologically advanced diagnostic tests to detect various genetic disorders in the region. The presence of key market players, and supportive regulatory frameworks are resulting in higher availability of well-advanced healthcare infrastructure. Moreover, the increasing R&D investments in genomics and personalized medicine will further stimulate the industry demand.
PCR Technologies Market Share
Few leading players in the PCR technologies industry include-
- Thermo Fisher Scientific Inc
- Agilent Technologies Inc
- Abbott Laboratories
- Eppendrof AG
- Sysmex Inostic Inc
- Qiagen
- Bio-Rad Laboratories Inc
- Takara Bio Inc
- F. Hoffmann-LA Roche Ltd
- Merck KGaA
- Fluidigm Corporation
- Promega Corporation
Key players in the PCR technologies industry are placing efforts, on research investments, development of innovative products, and strategic collaborations, for fostering technological advancements and market expansion. To illustrate, Abbott Laboratories has emerged as a key market participant attributed to its innovative molecular diagnostics solutions leading to advancements in PCR technologies and improved healthcare outcomes.
PCR Technologies Industry News
- In November 2023, Roche launched its next-generation qPCR system, the LightCycler PRO System, designed to be the most sophisticated qPCR technology for both clinical diagnosis and research.
- In March 2023, Thermo Fisher Scientific launched the Applied Biosystems™ QuantStudio™ Absolute Q™ AutoRun dPCR Suite, a digital PCR research solution that enables lab automation, and reduces overhead while maintaining consistency, flexibility, and ease of use.
What Information does this report contain?
Frequently Asked Questions (FAQ) :
